Valvublator

Valvublator is a medical device company developing a percutaneous catheter-based system for the decalcification and regeneration of heart valves. The company's technology aims to allow patients to keep their own heart valves instead of receiving prosthetic implants by using a combination of ultrasonic cleaning, bioelectric signaling to promote stem cell homing, and cell sodding. Valvublator is an incubator company within Leonhardt's Launchpads and is focused on treating conditions like aortic stenosis through a minimally invasive approach. The platform integrates multiple technologies including vibrational energy for plaque removal and bioelectric protein expression to stimulate tissue repair. The company is currently in the pre-clinical development stage, with its technology platform designed to address valvular insufficiency and prevent re-calcification.